Reduced expression of CDKN2A in leukocytes appears to be associated with increased CD14++CD16++ monocyte subsets, increased immune complex responses, and overproduction of pro-inflammatory factors in RA (2, 92). The gene discussed is CDKN2A; the disease is rheumatoid arthritis.